生物标志物 生物标志物
Pierre Champetier1,2, Claudia Albero1,2, Filipa Raposo Pereira3,4
1Sorbonne Université, Paris Brain Institute (ICM), INSERM, CNRS, UMR-1127, DreamTeam, Paris, France.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
概括
唤醒缓慢波 (wSW) 可能表明早期阿尔茨海默病 (AD) 变化. 较低的wSW密度和更高的振幅与粉样蛋白和神经退行有关,这表明潜在的早期AD生物标志物.
科学领域:
- 神经科学是一个神经科学.
- 生物标志物 生物标志物
- 阿尔茨海默氏症疾病研究研究
背景情况:
- 缓慢的睡眠波对于清除大脑废物和预防阿尔茨海默病 (AD) 病变至关重要.
- 唤醒缓慢波 (wSW),在唤醒EEG中观察到,随着睡眠剥夺而增加并预测错误.
- 这项研究调查了wSW特征与粉样蛋白和神经退行状态和过渡有关的特征.
研究的目的:
- 根据粉样蛋白 (A) 和神经退行 (N) 状态,比较老年人醒来缓慢波 (wSW) 特性.
- 检查过渡到粉样蛋白或神经退行正性的个体中的wSW特征.
- 探索wSW作为AD病理学的早期生物标志物的潜力.
主要方法:
- 利用了314名患有记忆障碍的老年参与者的EEG记录.
- 在基线和2年随访时使用PET扫描评估粉样蛋白和神经退行状态.
- 在delta和theta频段分析wSW密度和振幅,对共变量进行调整,并对多次比较进行校正.
主要成果:
- 与对照人群相比,在患有粉样蛋白或神经退行症的参与者中观察到较低的 delta wSW 密度.
- 患有粉样蛋白和神经退行症的个体在delta和theta波段中显示出更高的wSW振幅.
- 过渡到粉样蛋白或神经退行性阳性与改变的wSW特征 (更高的振幅或更低的密度) 相关.
结论:
- 唤醒慢波 (wSW) 特性显示了粉样蛋白沉积和神经退行早期EEG生物标志物的潜力.
- wSW指标可以通过简短的静止状态EEG测量,有助于早期识别有风险的个体.
- 这些发现表明wSW可以在认知能力下降之前检测临床前AD变化.
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516


